EDAP can treat prostate cancer by focusing ultrasound waves at just the target region, similar to how a magnify glass can focus light from the sun so intensely that it can burn a piece of paper, allowing it to eliminate the cancer while limiting side effects, CEO Ryan Rhodes explains to Bloomberg Intelligence. In this Vanguards of Health Care episode, Rhodes sits down with BI analyst Matt Henriksson to talk about his path from Intuitive Surgical to lead EDAP, how the Focal One robot uses high...

Haemonetics, a medical-device maker that focuses on markets including blood and plasma collection, is evolving to expand broadly with more diversification and greater sustainability over time, all with the view that good products win, CEO Chris Simon explains to Bloomberg Intelligence. In this Vanguards of Health Care podcast episode, Simon sits down with BI analyst Matt Henriksson to talk about Haemonetics and how its has built out its hospital franchise with M&A to include high-growth...

OrthoPediatrics’ aspiration is to develop anatomically appropriate implants, instruments and specialized braces for children, so surgeons don’t need to “MacGyver” their way with treating a child with adult sized devices, CEO David Bailey explains to Bloomberg Intelligence, referring to the multi-skilled character from the 1980s TV series. In this Vanguards of Health Care podcast episode, Bailey sits down with BI analyst Matt Henriksson for an in-depth interview to talk about OrthoPediatrics,...

“We’re staking the company on personalization: If you can make the health-care experience more personal to the individual, they’ll be more likely to engage around their health care and take the proper actions to get better outcomes,” Chris Michalak, CEO of Personify Health, tells Bloomberg Intelligence in this episode of the Vanguards of Health Care podcast. Michalak joins BI analyst Jonathan Palmer to discuss the merger of Virgin Pulse and HealthComp, the company’s AI-driven personalization...

Bolt Navigation has shrunk the use of a navigation system for spine surgery into an Apple iOS device, using the gyroscope-on-chip technology to make spinal fusion cases more accurate in any surgery setting, CEO Patrick West says. In this episode of Bloomberg Intelligence’s Vanguards of Health Care podcast, West sits down with BI analyst Matt Henriksson to talk about how the Bolt Navigation Unit leverages the gyroscope and an X-ray acquired once the patient is positioned for pedicle screw...

Modern medicine hasn’t made big strides in managing psychiatric disorders, a growing challenge with global implications. “The treatment of psychiatric disorders hasn’t changed from what it was like 30 years ago, medications are given by trial and error and we don’t really know what’s going to work,” Amit Etkin, CEO of Alto Neuroscience, tells Bloomberg Intelligence in this episode of the Vanguards of Health Care podcast. BI senior health-care associate Jean Rivera Irizarry joins Dr. Etkin for...

Vericel acquired a hidden gem in cartilage repair that other companies had written off, and developed it into a high-growth product that could potentially address a $4 billion market. In this episode of the Vanguards of Health Care podcast, Vericel CEO Nick Colangelo sits down with Matt Henriksson, Bloomberg Intelligence analyst, to talk about how MACI took over as the market leader for cartilage repair in the knee and its potential to do so for the ankle. Colangelo also discusses why the...

Dr. Stephen Hoge, Moderna’s head of R&D, joined the Vanguards of Health Care podcast to share his insights on the company’s groundbreaking work in messenger RNA. In this episode, Dr. Hoge and Bloomberg Intelligence’s Sam Fazeli take listeners into an in-depth conversation on how Covid was just the start of using mRNA as a way of treating disease. They also discuss Moderna’s cancer trials and its approach to rare diseases.  See omnystudio.com/listener for privacy information.

“We’re here to lower the cost of prescription drugs for every American,” Mark Thierer, CEO of Waltz Health explains to Bloomberg Intelligence in this episode of the Vanguards of Health Care podcast. Thierer joins BI senior health care analyst Jonathan Palmer to discuss Waltz’s Marketplace Search solutions for pharmacies and payers and why the upcoming launch of its Intelligent Specialty Engine is a game changer. He also shares his insights into the latest trends affecting the PBM...

“We are driving the market to exome and genome testing with a goal of making multigene panels be a thing of the past” Katherine Stueland, CEO of GeneDx, tells Bloomberg Intelligence’s analyst Jonathan Palmer on this episode of the Vanguards of Health Care podcast. They discuss GeneDx’s 80% market share in exome sequencing, the evolution of the genetic testing market and why the company’s core mission is delivering clinically-actionable results in rare diseases.   See omnystudio.com/listener...

Penumbra keeps a two-page list of key thrombectomy opportunities and technologies to innovate that allows it to keep transforming, presently with its computed-assisted vacuum technology (CAVT) for removing clots from the body, CEO Adam Elsesser explains to Bloomberg Intelligence. In this Vanguards of Health Care podcast episode, Elsesser sits down with BI analyst Matt Henriksson for an in-depth interview about Penumbra, how CAVT can sense the pressure differentials between clot and blood to...

Dexcom is expanding its portfolio of continuous glucose monitors (CGMs) with the launch of Stelo, balancing the needs of patients and payors to maximize the use of the technology, CEO Kevin Sayer explains to Bloomberg Intelligence. In this Vanguards of Health Care podcast episode, Sayer sits down with BI analyst Matt Henriksson for an in-depth interview about how G7, Dexcom’s flagship CGM, is capturing share in every market it’s in, how the launch of Stelo opens up CGM access to nearly 25...

Enovis is well positioned in the orthopedic market, combining small-cap focus on product innovation with large-cap functionality, CEO Matt Trerotola tells Bloomberg Intelligence. That includes its commercial team, balance sheet and M&A, which let it penetrate some of the fastest-growing segments. In this Vanguards of Health Care podcast episode, Trerotola sits down with BI analyst Matt Henriksson for an in-depth interview about Enovis, how its technology has gained an edge in shoulders...

When Wegovy was approved in 2021, patients began inquiring about whether Ro could build a product that would give them the “Ro experience” in weight loss: The company went to work at the end of 2021, spent all of 2022 building it, launched in 2023 and is now scaling up, CEO and co-founder Zachariah Reitano explains to Bloomberg Intelligence. In this episode of the Vanguards of Health Care podcast, Reitano sat down with BI analyst Jonathan Palmer to discuss how the Ro platform is uniquely...

Butterfly Network looks to streamline the ultrasound workflow and disrupt the incumbent market with its portable ultrasound technology that uses semiconductors instead of traditional crystals, CEO Joe DeVivo explains to Bloomberg Intelligence. In this Vanguards of Health Care podcast episode, DeVivo sits down with BI analyst Matt Henriksson to talk about Butterfly’s new iQ3 system that employs computer chips from TSMC (Taiwan Semiconductor Manufacturing Co.) to match the quality of...

“People who engage with an Included clinician experienced an average of two additional healthy days per month,” Owen Tripp, CEO of Included Health, explains to Bloomberg Intelligence. Tripp joins BI analyst Jonathan Palmer for this episode of the Vanguards of Health Care podcast for a wide-ranging discussion on why “healthy days” are Included’s North Star, the evolution of navigation and why over 30% of the Fortune 500 has contracted with the company. The conversation also covers Included’s...

CathWorks has developed a mapping platform for coronary arteries that streamlines cases, with a subscription model that can potentially accelerate its adoption and transition doctors away from traditional catheters, CEO Ramin Mousavi explains to Bloomberg Intelligence. In this Vanguards of Health Care podcast episode, Mousavi sits down with BI analyst Matt Henriksson to talk about CathWorks, how the FFRangio technology takes a routine angiogram exam, or X-ray, and its in-house AI algorithm to...

“We started this company looking at the current genomics field and evaluating the gap we’re trying to fill,” Molly He, CEO and co-founder of Element Biosciences, explains to Bloomberg Intelligence. Dr. He joins BI analyst Jonathan Palmer on this Vanguards of Health Care podcast episode to discuss the intricacies of building a new gene-sequencing instrument from scratch, the challenges of getting customers to adopt technology from new entrants and why the extension of the AVITI system beyond...

IRhythm Technologies’ Zio ambulatory cardiac monitors have the potential to change how doctors screen for irregular heartbeats by combining miniaturized biosensors and AI data analytics into a patch, CEO Quentin Blackford explains to Bloomberg Intelligence. In this Vanguards of Health Care podcast episode, Blackford sits down with BI analyst Matt Henriksson for an in-depth interview on iRhythm, how its Zio platform technology, powered by its second-generation AI network, allows patients to be...

Caira Surgical is innovating radar technology to make it precise enough for use in navigating surgeons through knee-replacement procedures, where every millimeter matters for an accurate outcome, co-founders Jon Greenwald and Mort Meftah explain to Bloomberg Intelligence. In this Vanguards of Health Care podcast episode, Greenwald and Meftah sit down with BI analyst Matt Henriksson for an in-depth interview about Caira, how sub-millimeter radar technology can be an improvement over...

Insulet is disrupting how patients can treat their diabetes, capitalizing on its differentiated Omnipod on-the-body delivery technology, CEO Jim Hollingshead explains to Bloomberg Intelligence. In this Vanguards of Health Care podcast episode, Hollingshead sits down with BI analyst Matt Henriksson for an in-depth interview on Insulet’s Omnipod patch pump technology, how on-the-body wear compares with traditional insulin pumps and opens access to patients still using syringes, and upcoming...

Johnson & Johnson has multiple robotic development projects that are set to expand its market-leading position in advanced surgical technology, Hani Abouhalka, company group chairman, Robotics & Digital, Johnson & Johnson Medtech, explains to Bloomberg Intelligence. In this Vanguards of Health Care podcast episode, Abouhalka sits down with BI analyst Matt Henriksson to talk about developments in J&J’s multiple robotic platforms, including the Monarch system for bronchoscopy...

Stereotaxis is developing robotic capabilities to enhance procedures for treating atrial fibrillation, with several innovations in the works. In this Vanguards of Health Care podcast episode, CEO David Fischel sits down with Bloomberg Intelligence analyst Matt Henriksson for a discussion about how the company’s Robotic Navigation System helps patients and future prospects for the use of robotics in cardiology surgery.  See omnystudio.com/listener for privacy information.

Amputation is never a desired outcome. That’s why Podimetrics is working on innovations, as well as public awareness, around early detection of diabetic ulcers to prevent unnecessary procedures, co-founder and CEO Jon Bloom explains to Bloomberg Intelligence. In this Vanguards of Health Care podcast episode, Jon sits down with BI analyst Matt Henriksson for an in-depth interview about Podimetrics, the state of diabetic ulcers and why current guidelines may be waiting until it is too late for...